- Report
- October 2024
- 1300 Pages
Global
From €3708EUR$3,900USD£3,115GBP
- Report
- November 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 187 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 89 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- November 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- May 2024
- 184 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- May 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2021
- 78 Pages
Global
From €761EUR$800USD£639GBP
- Report
- February 2024
- 210 Pages
Global
From €3945EUR$4,150USD£3,314GBP
- Report
- April 2023
- 450 Pages
Global
From €3793EUR$3,990USD£3,187GBP
- Report
- April 2023
- 200 Pages
Global
From €3755EUR$3,950USD£3,155GBP
- Report
- February 2024
- 210 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- March 2024
- 30 Pages
Global
From €2614EUR$2,750USD£2,196GBP
- Report
- October 2023
- 183 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- April 2023
- 147 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- October 2023
- 190 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2021
- 110 Pages
Global
From €6512EUR$6,850USD£5,471GBP
- Report
- November 2021
- 747 Pages
Global
From €3803EUR$4,000USD£3,195GBP

Cancer Targeted Therapy is a type of oncology drug that specifically targets cancer cells, leaving healthy cells unharmed. These drugs are designed to block the growth and spread of cancer cells, and can be used in combination with other treatments such as chemotherapy and radiation. Cancer Targeted Therapy drugs can be divided into two categories: small molecule drugs and monoclonal antibodies. Small molecule drugs are designed to target specific proteins or enzymes that are involved in the growth and spread of cancer cells, while monoclonal antibodies are designed to target specific molecules on the surface of cancer cells.
The Cancer Targeted Therapy market is an important part of the oncology drug market, as it offers a more targeted approach to treating cancer. This type of therapy is becoming increasingly popular due to its ability to reduce side effects and improve patient outcomes.
Some companies in the Cancer Targeted Therapy market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more